MedTrace Logo

Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)

NCT03813550 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-02-04

No results posted yet for this study

Summary

This study aims to demonstrate a potential association between gut microbiota composition, plasma levels of various forms of vitamin K, and severity of clinical manifestations of Pseudoxanthoma Elasticum (PXE).

Conditions

  • Pseudoxanthoma Elasticum

Interventions

DIAGNOSTIC_TEST

Fecal and blood samples

Fecal samples for intestinal microbiota analysis; Blood and fecal samples for assessment of various forms of vitamin K

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER

  • Biofortis Mérieux NutriSciences

    collaborator OTHER

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Ludovic MARTIN, MD, PhD · Department of Dermatology, University Hospital of Angers

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2020-01-30
Completion
2020-01-30

Countries

  • France
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03813550 on ClinicalTrials.gov